Continuous intrauterine compared with cyclic oral progestin administration in perimenopausal HRT

Maturitas

Volumn 46, Issue 1, 2003, Pages 69-77

  Boon, Janine ^a   Scholten, Piet C ^a   Oldenhave, Anna ^b   Heintz, A Peter M ^b  

^a DEPARTMENT OF SURGERY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Hormone replacement therapy; Intrauterine system; Perimenopause

Indexed keywords

ESTROFEM; GESTAGEN; LEVONORGESTREL; TRISEQUENS;

ADULT; ARTICLE; CLIMACTERIUM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ENDOMETRIUM HYPERPLASIA; FEMALE; HORMONE SUBSTITUTION; HUMAN; INTERMETHOD COMPARISON; NORMAL HUMAN; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; VAGINA BLEEDING;

EID: 0042733740     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(03)00163-4     Document Type: Article

References (29)

1. Oldenhave A., Jaszmann C.J.B., Haspels A.A., et al. Impact of climacteric on well-being: a survey based on 5213 women 39 to 60 years. Am. J. Obstet. Gynecol. 168:1993;772-780.
2. Mc Kinlay S.M., Brambilla D.J., Posner J.G. The normal menopause transition. Maturitas. 14:1992;103-115.
3. Tuppurainen M., Kröger H., Honkanen R., Puntila E., Huopio J., Saarikoski S., Alhava E. Risks of perimenopausal fractures - a prospective population based study. Acta Obstet. Gynecol. Scand. 74:1995;624-628.
4. Ross R.K., Paganini-Hill A., Mack T.M., Henderson B.E. Cardiovascular benefits of oestrogen replacement therapy. Am. J. Obstet. Gynecol. 160:1989;1301-1306.
5. Pickar J.H., Thorneycroft I., Whitehead M. Efects of hormone replacement therapy on the endometrium and lipidparameters: a review of randomized clinical trials, 1985-1995. Am. J. Obstet. Gynecol. 178:(5):1998;1087-1099.
6. Ziel H.K. Estrogen's role in endometrial cancer. Obstet. Gynecol. 60:1982;509-514.
7. Gambrell R.D. Prevention of endometrial cancer with progestogens. Maturitas. 8:1986;159-168.
8. Dören M., Schneider H.P.G. The impact of different HRT regimen on compliance. Int. J. Fertil. Menopausal Study. 41:1996;29-31.
9. Whitehead M.I., Hillard T.C., Crook D. The role and use of progestogens. Obstet. Gynecol. 75:(4(S)):1990;59s-76.
10. Tikkanen M.J. The menopause and hormone replacement therapy: lipids, lipoproteins, coagulation and fibrinolytic factors. Maturitas. 23:1996;209-216.
11. Raudaskoski T.H., Lahti E.I., Kauppila A.J., Apaja-Sarkkinen M.A., Laatikainen T.J. Transdermal oestrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses. Am. J. Obstet. Gynecol. 172:1995;114-119.
12. Andersson K., Mattsson L.A., Rybo G., Stadberg E. Intrauterine release of levonorgestrel - a new way of adding progestogen in hormone replacement therapy. Obstet. Gynecol. 79:1992;963-967.
13. Mattsson L.-Å., Cullberg G., Samsioe G. Evaluation of a continuous estrogen-progestogen regimen for climacteric complaints. Maturitas. 4:1982;95-102.
14. Silverberg S.G., Haukkamaa M., Arko H., Nilsson C.G., Luukkainen T. Endometrial morphology during long-term use of levonorgestrel releasing intrauterine devices. Int. J. Gynecol. Pathol. 5:1986;235-241.
15. Nilsson C.G., Haukkamaa M., Verola H., Luukainen T. Tissue concentrations of levonorgestrel in women using a levonorgestrel releasing IUD. Clin. Endocrinol. 17:1982;529-536.
16. Andersson K., Rybo G. Levonorgestrel releasing intrauterine device in the treatment of menorrhagia. Br. J. Obstet. Gynecol. 97L:1990;690-694.
17. Scholten P.C. The levonorgestrel IUD. Clinical performance and impact on menstruation. 1989;OMI Grafisch Bedrijf, Utrecht, Netherlands. ISBN 90-9003100-6.
18. Nilsson C.G., Lähteenmäki P.L.A., Luukkainen T., Robertson D.N. Sustained intrauterine release of levonorgestrel over 5 years. Fertil. Steril. 45:1986;805-807.
19. McKinlay S.M. The normal menopause transition: an overview. Maturitas. 23:1996;137-145.
20. Janssen C.A.H., Scholten P.C., Heintz A.P.M. A simple visual assessment technique to discriminate between menorrhagia and normal menstrual blood loss. Obstet. Gynecol. 85:1995;977-982.
21. Belsey E.M., Farley T.M. The analysis of menstrual bleeding patterns: a review. Contraception. 38:1988;129-158.
22. Burger H.G. The endocrinology of the menopause. Maturitas. 23:1996;129-136.
23. Smith P., Bakos O., Heimer G., Ulmsten U. Transvaginal ultrasound for identifying endometrial abnormality. Acta Obstet. Gynecol. Scand. 70:1991;591-594.
24. Jänne O., Ylöstalo P. Endometrial oestrogen and progestin receptors in women bearing a progesterone-releasing intrauterine device. Contraception. 22:1980;19-23.
25. Shaaban M.M. The perimenopause and contraception. Maturitas. 23:1996;181-192.
26. Sivin I., Stern J. Health during prolonged use of levonorgesrel 20 micrograms/day and the copper Tcu 380Ag intrauterine contraceptive devices: a multicenter study. International Committee for Contraception Research (ICCR). Fertil. Steril. 61:(1):1994;70-77.
27. Suhonen S., Allonen H., Lähteenmäki P. Sustained-release estradiol implants and a levonorgestrel releasing intrauterine device in hormone replacement therapy. Am. J. Obstet. Gynecol. 172:1995a;562-567.
28. Suhonen S., Holmström T., Allonen H., Lähteenmäki P. Intrauterine and subdermal progestin administration in postmenopausal hormone replacement therapy. Fertil. Steril. 63:1995b;336-342.
29. Suhonen S., Halmstroom T., Lahteenmaki P. Three year follow up of the use of a levonorgestrel releasing intrauterine system in hormone replacement therapy. Acta Obstet. Gynecol. Scand. 76:(2):1997;145-150.